HERON THERAPEUTICS, INC. /DE/ 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Dec 15, 2014
Insider Transaction Report
Form 4
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-12-12+45,000→ 45,000 totalExercise: $9.05Exp: 2024-12-12→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.